3810 results for «2258»

Filter By

3810 results

Shaping the future of structural heart disease intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Shaping the future of structural heart disease intervention

PCI after TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session

Rapid-fire - LAA closure and plugging

17 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....

TAVI and future coronary access - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

TAVI and future coronary access - LIVE case

PCR Tokyo Valves 2024 Closing Ceremony

18 Feb 2024 – From PCR Tokyo Valves 2024

The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...

PCR Tokyo Valves 2024

The role of WATCHMAN therapy in optimising results and future perspectives

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve

TAV-in-TAV interventions: a new frontier in TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...

TAV-in-TAV interventions:

Mitral and tricuspid intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!

Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...

Rapid-fire - Pulmonary and tricuspid valve implantation

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.

Rapid-fire - Pulmonary and tricuspid valve implantation

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Jon DeHaan Foundation Award ceremony

14 May 2024 – From EuroPCR 2024

This session is the Jon DeHaan Foundation Award ceremony, recognizing and celebrating outstanding achievements in the field of interventional cardiology.

Jon DeHaan Foundation Award ceremony

Management of patient with coronary artery disease and left ventricle dysfunction

15 May 2024 – From EuroPCR 2024

This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...

Management of patient with coronary artery disease and left ventricle dysfunction

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Imaging-guided PCI for stent failure - LIVE case

16 May 2024 – From EuroPCR 2024

An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...

Imaging-guided PCI for stent failure - LIVE case

Antiplatelet de-escalation after complex PCI: when and how?

15 May 2024 – From EuroPCR 2024

Antiplatelet de-escalation after complex PCI

Asymptomatic severe aortic stenosis: Will these trials change my practice?

16 May 2024 – From EuroPCR 2024

This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...

Asymptomatic severe aortic stenosis

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care

16 May 2024 – From EuroPCR 2024

This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care
Didn’t find what you were looking for?